The FDA is warning diabetes patients that information from CGMs, insulin pumps, and automated dosing systems could fail to be delivered if smartphone settings are not properly configured. In a new FDA ...

FDA Director General Muhammad Asif Chaudhry told the media that an attempt to encroach on the land of FDA-owned shops in Ahmad Nagar locality was also thwarted and structures were demolished on ...

On 29 January, SPIE, the international society for optics and photonics, recognized the top-rated new optics and photonics products with the industry-focused Prism Awards. The gala evening ...

The Company will host a webcast to discuss the PRISM interim data and additional analyses from ... preclinical development and have not yet been approved for marketing by the FDA or any other ...

The Company will host a webcast to discuss the PRISM interim data and additional analyses from the 4D-150 program in wet AMD and diabetic macular edema (DME) on Monday, February 10, 2025 at 8:00 a ...

The new indications, approved Tuesday by the FDA, make Ozempic the most broadly indicated drug in its class, with the largest set of specific medical conditions that it may be prescribed to treat.

Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been given the U.S. Food and Drug Administration (FDA)'s highest risk level.

An audit released by the Inspector General of the U.S. Department of Health and Human Services, the parent organization of the Food and Drug Administration (FDA), is not a pleasant read. Let us turn ...

It’s not clear if the changes are temporary or if the pages will be restored. When asked about the removed webpages, an FDA spokesperson directed MedTech Dive to contact the Department of Health and ...

Red 3 – also called FD&C Red No. 3, erythrosine or E127 – has been widely used in food, cosmetics and pharmaceuticals since its FDA approval in 1969. You’ve likely encountered Red 3 before.

As of the FDA's last update on Jan. 15, authorities were investigating multiple outbreaks of E. coli and Listeria. Publication of the Centers for Disease Control and Prevention's authoritative ...

The FDA's Diversity Action Plan draft guidance to drug and medical device companies stems from the 2022 Food and Drug Omnibus Reform Act. It aims to significantly increase participation of ...